Diverse convergent evidence in the genetic analysis of complex disease: coordinating omic, informatic, and experimental evidence to better identify and validate risk factors.

If one is interested in filtering a large list of nominally significant findings (p < 0.05) to identify a subset most worthy of follow-up, instead of characterizing the evidence for a single finding, our flexible scoring system can be utilized in this setting as well.

also in 7,732 other papers